• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Clinical Trial Recruitment

Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment

by Jasmine Pennic 04/07/2025 Leave a Comment

Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment

What You Should Know:  - Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials. - The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.  Enhance
Read More

Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching

by Syed Hamza Sohail 12/09/2024 Leave a Comment

Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company

What You Should Know: - Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.  - The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.  Carta Healthcare and Realyze Intelligence:
Read More

Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

by Syed Hamza Sohail 08/08/2024 Leave a Comment

Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

What You Should Know: -  Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel Network partnership with Belong.Life, a leading global provider of disease-specific AI-powered patient education and support solutions, to identify and connect qualified patients with clinical research. -  Through this partnership, Trialbee and Belong.Life will streamline the recruitment process and introduce clinical research to millions of
Read More

myTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial Recruitment

by Jasmine Pennic 09/13/2023 Leave a Comment

myTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial Recruitment

What You Should Know:  - Congenica, a digital health company specializing in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide. - The strategic partnership between Congenica and myTomorrows will open new opportunities for physicians to search for access to
Read More

How to Achieve Health Equity in Decentralized Clinical Trials

by Katrina Rice, Chief Delivery Officer, Biometrics Services at eClinical Solutions 06/29/2023 Leave a Comment

How to Achieve Health Equity in Decentralized Clinical Trials

Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More

ProKidney Taps CVS Health Clinical Trial Services for Precision Recruitment

by Fred Pennic 01/31/2023 Leave a Comment

ProKidney Taps CVS Health Clinical Trail Services for Precision Recruitment

What You Should Know: - CVS Health Clinical Trial Services and late clinical-stage cellular therapeutics company ProKidney Corp. today announced a collaboration to enroll patients with type 2 diabetes and chronic kidney disease into the proact 1 (REGEN-006) Phase 3 clinical trial of REACT®. ProKidney’s lead product candidate, REACT® (REnal Autologous Cell Therapy), is a first-of-its-kind, patented, autologous cellular therapy with the potential to not only slow and stabilize the
Read More

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

by Dr. Chris Fourment, SVP of Clinical Strategy at Iterative Health 01/24/2023 Leave a Comment

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.   There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More

C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy

by Syed Hamza Sohail 01/05/2023 Leave a Comment

C2i Genomics & AstraZeneca Team Up to Advance Cancer Therapy

What You Should Know: - C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.  - The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers. - Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More

Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation

by Fred Pennic 04/21/2022 Leave a Comment

Reify Health Secures $220M to Support Clinical Trial Diversity

What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B.  - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More

THREAD Acquires Clinical Trial Recruitment Solution CureClick

by Health M&A Activity 04/20/2022 Leave a Comment

THREAD Acquires Clinical Trial Recruitment Solution CureClick

What You Should Know: - THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments and decentralized clinical trials has acquired CureClick, which offers the world’s first proprietary crowdsourcing platform designed to accelerate awareness and participation in clinical research. This acquisition follows THREAD’s recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry’s leading
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |